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PENGGUNAANSTRATEGIFERMENTASIDAN 
PENULENAN BAGI PENINGKATAN HASIL ANTIGEN BmRl 
ABSTRAK 
Brugia Rapid merupakan UJian diagnostik komersial yang digunakan untuk 
mengesan jangkitan terhadap Brugia malayi dan Brugia timori (filariasis brugia). 
Ujian ini merupakan format ujian batang pencelup aliran sehala yang menggunakan 
antigen rekombinan BmR1 yang diekspreskan daripada klon 
Bm17DIII/pPROEX™HTITOP 10. Oleh kerana penggunaan ujian 1ini mendapat 
permintaan yang tinggi di pasaran, maka peningkatan penghasilan ke skala besar dan 
peningkatan efisiensi penulenan adalah perlu untuk mengurangkan kos penghasilan 
ujian tersebut. 
Pengkulturan ke atas bakteria rekombinan ini dijalankan melalui kaedah fermentasi 
kultur sekelompok, di mana sel ditumbuhkan di dalam media kaldu "Terrific" 
terubahsuai dan glukosa disuapkan secara eksponen pada kadar yang terkawal 
menggunakan "Multifermenter Control Software" (MFCS) untuk suapan secara 
automatik semasa sebelum dan selepas aruhan. Kepelbagaian ke atas kadar 
pertumbuhan spesifik menunjukkan kepekatan akhir sel sebanyak 24.3 g/1 diperolehi 
pada kadar pertumbuhan spefisik ditetapkan pada 0.15 h-I, diikuti dengan sua pan 
pada kadar yang tinggi selepas aruhan. Walau bagaimanapun, didapati peningkatan 
yang lebih tinggi ke atas kadar pertumbuhan spesitik tidak meningkatkan hasil sel, 
sebaliknya mengurangkan penghasilan protein rekombinan BmRl. Didapati 
xiv 
penghasilan tertinggi protein rekombinan BmR1 sebanyak 9.82 g/1 diperolehi apabila 
suapan dilakukan pada kadar tetap yang rendah (1.9 ml/min), digabungkan dengan 
kadar pertumbuhan spesifik yang dikawal pada 0.075 h-1. Selain itu juga, dapat 
diperhatikan bahawa pada kadar ini, produktiviti spesifik keseluruhan, hasil koefisien 
fermentasi [hasil biomas (Yx/s) dan hasil produk (Yp/s)] adalah yang tertinggi 
dibandingkan dengan proses lain. Strategi ini telah berjaya mengawal pengumpulan 
bahan-rencatan asid asetik di bawah tahap rencatan iaitu 1.26 g/1. 
Ekspresi terhadap antigen rekombinan BmRl adalah optimum dengan dua kali 
aruhan IPTG berkepekatan 1 mM. Aruhan yang dilakukan pada fasa log pertengahan 
I 
telah menghasilkan protein terlarut dalam jumlah yang signifikan. Oleh itu, 
penulenan antigen rekombinan BmR1 dilakukan melalui penulenan tidak temyahasli 
(non-denaturing) kromatografi afiniti logam tidak bergerak ("immobilized metal 
affinity chromatography"). 
Kajian mempelbagaikan isipadu penimbal pembasuh, kepekatan imidazol dan garam 
telah dijalankan untuk meningkatkan efisiensi proses penulenan protein. Kepekatan 
imidazol pada 20 mM adalah yang terbaik di mana ia memberikan kepekatan antigen 
rekombinan BmR1 yang tertinggi dengan ketulenan yang baik. Apabila penimbal 
basuhan sebanyak lima isipadu kolum digunakan semasa proses penulenan, hasil 
kepekatan antigen rekombinan yang diperolehi adalah sebanyak 5.14 mg/1, 
dibandingkan dengan hasil yang diperolehi iaitu sebanyak 2.84 g/1 apabila 10 isipadu 
kolum penimbal basuhan digtmakan. Hasil keseluruhan protein sasaran meningkat 
sebanyak tujuh kali ganda dibandingkan dengan hasil protein yang diperolehi melalui 
kaedah konvensiorial pengkulturan di dalam kelalang. 
XV 
Tahap sensitiviti dan spesifisiti antigen rekombinan BmR1 yang dihasilkan dalam 
kajian ini ditentukan melalui ujian Pemblotan Western dan dua lagi ujikaji imunoasai 
iaitu ELISA dan ujian pantas imunokromatografi. Melalui kaedah ELISA, didapati 
antigen rekombinan BmR1 yang dihasilkan dalam kajian ini mengekalkan sifat 
antigenik apabila dikesan oleh serum pesakit .filariasis (1 00% sensitif) dan tidak 
bertindakbalas apabila diuji menggunakan serum dari jangkitan lain dan individu 
yang sihat (1 00% spesifik). Apabila ia diaplikasikan pada ujian pantas, antigen 
rekombinan BmR1 bertindakbalas terhadap antibodi anti-filaria di dalam serum 
pesakit yang dijangkiti dengan Brugia malayi dan menunjukkan tahap sensitiviti 
100%. Oleh itu, antigen rekombinan BmR1 yang dihasilkan ini adalah sesuai untuk 
I 
digunakan dalam penghasilan kit Brugia Rapid™. 
Secara keseluruhannya, kajian ini mencadangkan penambahbaikan, kaedah yang 
lebih efisien, dan lebih jimat ke atas proses penghasilan berskala besar dan proses 
hiliran antigen BmRl, seterusnya sesuai untuk aplikasi industri. 
xvi 
UTILIZATION OF FERMENTATION AND PURIFICATION 
STRATEGIES TO ENHANCE THE YIELD OF 
BmRl ANTIGEN 
ABSI'RACT 
Brugia Rapid TM is an established diagnostic test that is commercially available. to 
detect infection to both B. malayi and B. timori infections (brugian filariasis). The test 
is a dipstick lateral flow test format that utilizes BmRl recombinant antigen 
expressed by the clone Bml7DJII/pPROEX™HTITOP 10. Due to a significant 
demand for the test in the market; there is a need to scale up the production of the 
recombinant antigen and increase the purification efficiency to reduce the production 
cost of the test. 
The cultivation of the recombinant bacteria was performed usmg fed-batch 
fermentation where cells were grown in a modified Terrific broth medium and 
glucose was fed exponentially at a controlled rate using Multifermenter Control 
Software (MFCS) for automated feeding during pre-induction and post-induction 
feeding. Varying the specific growth rate (!l) prior to induction showed that a final 
cell concentration of 24.3 g/L was obtained at specific growth rate of 0.15 h-1 with 
feeding at high rate during post-induction. However, further increase of the specific 
growth rate during pre-induction feeding does not produce a higher cell mass, in fact 
it decreased the BmRl recombinant protein production. It was found that the highest 
BmRl production of 9.82 g/L was obtained when the feeding was carried out at low 
constant rate (1.9 ml/min), combined with the specific growth rate controlled at 
xvii 
0.075 h-1• It was also observed that at this feeding rate, the overall specific 
productivity, the fermentation yield coefficients [biomass yield (Y xis) and product 
yield (Ypts)] was the highest amongst all the runs tested. This strategy has 
successfully controlled the accumulation of acetic acid by-inhibitory product below 
the reported growth inhibitory level of 1.26 giL .• 
The expression of BmRl recombinant antigen was found to be optimal with twice 
induction of 1 mM of IPTG concentration. Initiation of expression at mid log had 
generated significant amounts of the soluble protein. Therefore, the BmR1 
recombinant antigen was then purified under non-denaturing conditions using 
immobilized metal affinity chromatography. 
In order to increase the efficiency of purification process, various volumes of wash 
buffer, imidazole and salt concentration were performed. Imidazole at 20 mM was 
fcund to be the best concentration that gave the best yield of BmRl recombinant 
antigen while achieving sufficient purity. When 5 column volumes (CV) of washing 
buffer was used in the purification step, the production of BmRl recombinant antigen 
was 5.14 mg/1; as compared to 2.84 mg/1 when 10 CV of washing buffer was 
employed. The overall production of the target protein was improved seven-fold 
compared to the conventional flask cultivation method. 
The sensitivity and specificity of the purified BmRl recombinant antigen produced in 
this study was confirmed by Western blot and two other immunoassays techniques 
namely ELISA and immunochromatographic rapid test. By the ELISA technique, it 
was found that the BmRl recombinant antigen produced in this study retained its 
xviii 
CHAPTER ONE 
INTRODUCTION 
1.1 Introduction to lymphatic filariasis 
1.1.1 Lymphatic filariasis 
Lymphatic filariasis (LF), or more commonly known as elephantiasis, is a parasitic 
disease caused by thread-like worms that live in the human lymphatic system. This 
disease is widespread and occurs throughout the tropical and sub-tropical regions of 
the world, such as Asia, Africa, Central and South America (Figure 1.1). The World 
Health Organization (WHO) has identified lymphatic filariasis to be one of the six 
infectious diseases that has the potential to be eliminated as a public health problem 
(WHO, 1998). Consequently a global programme for elimination of the disease 
known as the 'Global Programme to Eliminate Lymphatic Filariasis' (GPELF) was 
initiated in year 2000. In 2006, WHO has reported that more than 20% of the world's 
populations are at risk of acquiring LF. Meanwhile, it is estimated that over 120 
million of people in at least 83 countries in the world have already been infected and 
more than 40 million people are incapacitated by the disease (The Global Alliance to 
Eliminate Lymphatic Filariasis (GAELF), http://www.tilariasis.org). Statistics have 
shown that over 25 million men suffered from the genital form of the disease, while 
more than 15 million of people suffered from lymphoedema or elephantiasis of the 
leg. Out of this, 90% of the cases are caused by Wuchereria bancrofti whereas 
Brugia malayi accounts for about 10% (or 13 million) of the infected people 
especially in South and Southeast Asia, South Korea, and parts of China. However, 
Brugia timori is only restricted to Timor Leste and a few islands in Indonesia 
(Michael,2000) 
Figure 1.1 
-
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World endemic countries oflymphatic filariasis in 2006 
DIR Source: L)mpholic Filllriasis Elinilrllion Programme M11p 
Productiort Nlltc He .... ~~ llldGIS 
C~~~trntllicable Diseases (COS) World- Org111ization 
Source: http:/ /gamapserver. who. intlmapLibrary/ app/searchResults. aspx 
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Lymphatic filariasis is a major cause of permanent disability and disfigurement in the 
endemic areas. The areas endemic for this disease are underdeveloped and poor, 
hence it is known as the disease of poverty. Most often, young children get infected 
before the age five and it takes years before the infection can be clinically detected. 
Besides, the infection also has serious clinical eonsequences for pregnant women and 
infants. Once infected, the disease will slowly develop and the patient may suffer 
from disfiguration with swelling of the limbs and breasts (lymphoedema) and 
genitals (hydrocele), or swollen limbs with dramatically thickened, hard, rough and 
fissured skin (elephantiasis) This scenario will prevent the patients from 
experiencing normal working and social life because of physiological consequences 
and obvious physical handicap. As a result, this will lead to economic instability due 
to loss of manpower and decreased productivity which will aggravate the cycle of 
poverty (http://www.{ilariasis.org). 
1.1.2 Transmission and life cycle 
There are three lymphatic filaria that infect human namely Wuchereria bancrofti, 
Brugia malayi and Brugia timori. The disease is being transmitted to human by the 
bite of more than 70 species and subspecies of mosquitoes mainly Anopheles, Aedes, 
Culex and Mansonia; hence it is referred to as a vector-borne disease (Stone et al., 
1959; Nanduri and Kazura, 1989). The three lymphatic filariae have similar biphasic 
life cycle where larval development takes place in mosquito (intermediate host) and 
adult development takes place in the human (definitive host). Basically, there are 
four different stages of the life cycle of lymphatic filaria as depicted in Figure 1.2. 
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Mosquito ingests microfilariae as part of its blood meal. Within a few hours, the 
microfilaria penetrates the mosquito gut wall, migrates to the flight muscles and 
molts to the second larval stage (L2). The L1 and L2 molt takes place between days 6 
to 10 depending on the environmental conditions. After several days, the parasite 
undergoes an additional molt to the L3 parasite. The L3 then migrates from the flight 
muscles to the mouth parts of the vector, where they are positioned to be passed on to 
the vertebrate host during a subsequent blood meal (Scott, 2000). 
Infection is initiated by the deposition of the third stage larvae (L3) on the skin of 
human host following a bite by an infective mosquito. In the definitive host, the 
larval undergo an additional molt to the fourth larval stage (L4) between days 9 and 
14 post-infection as they mature into the lymphatic-dwelling adult male and female 
worms to complete the life cycle. Adult female parasites can remain reproductively 
active for more than 5 years. The lymphatic-dwelling filariae are diecious and 
undergo ovoviviparous reproduction resulting in the release of fully formed, sheathed 
first stage larvae (L1 of micro filariae) from the female. Then, the micro filariae enter 
the peripheral circulation of the human host where they are available to be ingested 
by the vector during a blood meal (Scott, 2000). 
The unique characteristic of the microfilaria (mf) stage of the parasites is that they 
have "periodicity" that restricts their appearance in the blood to only certain periods 
of the day. In general, the micro filariae can be classified into two main groups based 
on their circadian rhyihms; i) the noctural periodic strain, ii) the nocturnaly 
subperiodic strain. In the nocturnally periodic strain, they virtually disappear from 
the peripheral circulation and are found predominantly in the blood vessels of lungs 
5 
and deep tissues during the daytime. Conversely, during the night time (especially 
between 10 pm until 2 am), the micro filariae can be found in the peripheral blood. 
Meanwhile, for the nocturnally subperiodic strain, the mf is present in the blood both 
day and night but the density is much more higher during the night and tend lose 
their sheath in the process of dying on microscope slides (Bowman et a/., 2002). In 
addition to this basic strain, there is also nonperiodic or diurnally subperiodic strain 
of mf found in the South Pacific where it is transmitted mainly by day-biting 
mosquitoes of genus Aedes (Nanduri and Kazura, 1989). 
In Malaysia, the predominant strain is the nocturnal subperiodic B. ma/ayi. Due to its 
predominant appearance in blood at night, conventional diagnostic method is by 
microscopic examination of night bl~od. Studies of Wuchereria and Brugia species 
suggested that their periodicity is due to the difference in the oxygen tension between 
the arterial and venous blood in the lungs (Hawking and Gammage, 1968; Burren, 
1972; Nanduri and Kazura, 1989). However, Wang and Saz (1974) suggested that 
these parasites have adapted their periodicity to the vector feeding behavior, possibly 
to facilitate their transmission (Nanduri and Kazura, 1989). 
1.1.3 Brugia malayi 
Brugian filariasis is caused by Brugia malayi infection and it is endemic in parts of 
India, China, Indonesia, Philippines, Thailand, Vietnam and Malaysia (WHO, 1998). 
This species was first identified by Lichtenstein and named by Brug in 1927. The B. 
malayi species is classified under the family of Filariidae and the genus of Brugia. 
The distribution of B. malayi is very similar to that of W bancrofti. However, the 
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differences between W bancrofti, B. malayi and B. timori reside in their 
epidemiology, vectors, reservoirs, symptoms, but mainly the species morphology. 
The brugia female worm measures 43 to 55 mm in length by 130 to 170 !J.m in width, 
and male worm measures 13 to 23 mm in length by 70 to 80 /lffi in width. Adult 
worms produce microfilariae, measuring 177 to 230 !J.m in length and 5 to 7 !J.m in 
width (Figure 1.3), which are sheathed and have nocturnal periodicity 
(http://www.dpdcdc.gov). The adult male and female worms of B. malayi inhabit 
primarily the lumen of lymphatics whereby the microfilariae usually migrate from 
the lymphatics into the blood stream (Nanduri and Kazura, 1989). 
In Malaysia, the mam species of parasite causmg lymphatic filariasis are the 
subperiodic strains of B.malayi. This parasite is principally transmitted by 
mosquitoes belonging to the species Mansonia bonneae, M dives, M uniforms and 
M Indiana (Chang et al., 1991; Kwa, 2008). Generally, brugian filariasis leads to 
symptoms and manifestations that may include recurrent fever, lymphatic damage, 
renal damage, adenolymphangitis, lymphoedema, elephantiasis and pulmonary 
disease. However, the infection is usually limited to legs below the knee and upper 
limbs distal to elbow. 
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Figure 1.3 Microfilaria of Brugia malayi 
Source: http://www.dpd.cdc.gov/dpdx!HTML!ImageLibrary/Filariasis il.htm 
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1.1.4 Clinical manifestation 
In areas where LF is endemic, majority of the infected individuals fall into the 
following categories: asymptomatic amicrofilaraemia, symptomatic microfilaraemia, 
asymptomatic microfilaraemia, acute infection with filarial fever and 
adenolymphangitis (inflammation of the lymphatics and lymph nodes), chronic 
elephantiasis and occult filariasis. Asymptomatic amicrofilaraemia individuals are 
the infected persons who do not exhibit any physicals symptom and has no 
circulating microfilaria. Microfilaraemic individuals are those with microfilaria 
circulating in their blood, and they may have symptoms (symptomatic) or have no 
physical symptom (asymptomatic). Individual with acute symptoms may experience 
fever, chill, malaise, headache and vomiting. However, lymphoedema is the worst 
clinical manifestation of lymphatic filariasis and the chronic stage of lymphoedema 
is elephantiasis. 
The clinical manifestations of LF vary from one endemic area to another and also 
differ to some extent on the species of the parasite. For example, in parts of Africa 
where bancroftian filariasis is prevalent, the most common clinical form of the 
disease is hydrocoele while tropical pulmonary eosinophilia has been reported most 
commonly from the India subcontinent and Brazil. Meanwhile, it is recognized that 
inguinal lymphadenitis and lymphangitis are more common in brugian filariasis with 
the exceptions of genital disease (hydrocoele and filarial scrotum) (Kumaraswami, 
2000). 
9 
1.1.5 Diagnosis of lymphatic filariasis 
The diagnosis of brugian LF caused by B. malayi and B. timori can be performed 
using conventional laboratory methods such as thick blood smear technique, DNA-
based laboratory assay using the PCR technique, ultrasonography and 
immunoassays. For thick blood smear technique, a drop of blood is spread onto the 
slide, dried, stained and examined under the microscope for the presence of 
microfilariae. This method is insensitive for active infections; it misses people ·with 
low mf counts and those with amicrofilaremic infections; these individuals have the 
potential to contribute to future transmission. In addition, night blood collection is 
troublesome to both the staff and villagers and impractical in some endemic areas 
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(Weil and Ramzy, 2006). The sensitivity of this technique can be improved by 
membrane filtration of 1-5 ml of blood prior to microscopy. 
Molecular diagnostics by PCR is available for LF diagnosis. The main obstacle with 
the PCR method is that it requires sophisticated laboratory equipment and trained 
personnel to perform the analysis; and requires several hours to obtain the results. 
Thus, it is not practical to be used with large number of samples and for field 
screening. In addition, PCR generally do not detect people with amicrofilaraemic 
infection and still requires night blood smear for maximum sensitivity. 
Ultrasonography, the detection is based on 'filarial dance sign' which refers to live 
adult worm inside the lymphatic vessels. Other than not suitable for large scale 
studies, it is not very useful for brugian filariasis in which the adult worms are not 
found in the peripheral lymphatics. 
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Immunoassays detect the presence of specific antigens or antibodies in the blood of 
individuals. Antigen detection assay is not available for brugian filariasis. With 
regard to detection of specific antibodies, it was recognized that the elevated levels 
of IgG4 is a marker of active infection rather than past exposure and it does not 
cross-react with antigens from non-filarial helminthes (Lal and Ottesen, 1988; Kwan-
Lim eta/., 1990; Turner et al., 1993; Haarbrink eta/., 1995; Chanteau et al., 1995; 
Terhell et al., 1996; Rahmah et al., 1998). To date, there are two commercialized 
rapid tests for diagnosis of brugian lymphatic filariasis which is based on detection of 
anti-filarial IgG4 antibody test namely Brugia Rapid™ and PanLF Rapid™. The 
latter is for detection of both brugian and bancroftian filariasis and also employs the 
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BmR1 recombinant antigen. 
1.1.6 Elimination of lymphatic filariasis 
In 1997, the WHO advocated the global elimination ofLF as a public health problem 
and targeted to eliminate the disease by the year 2020. In conjunction with this, three 
years later (year 2000), the Global Alliance to Eliminate Lymphatic Filariasis 
(GAELF) was formed with the sole purpose of supporting the Global Programme to 
Eliminate Lymphatic Filariasis (GPELF). This programme aims to eliminate LF by 
interrupting the transmission of infection and to alleviate and prevent both suffering 
as well as disability caused by the disease. 
(flttp:l/www. filariasis. orglresources/ globalalliancehistory. htm). 
In order to interrupt the transmission of the infection, the entire 'at risk' population 
must be treated for a period long enough to make sure that level of microfilariae in 
the blood remain below that necessary to sustain transmission. In this case, a single 
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dose of two drugs regimens has being advocated ( albendazole 400 mg plus 
diethylcarbamazine (DEC) 6 mg/kg, or albendazole 400 mg plus ivermectin 200 
11g/kg) for a period of 4-6 years corresponding to the reproductive life span of the 
parasite (Ottesen, 2000). 
In addition to alleviate suffering and decrease the disability caused by LF disease, a 
principal strategy focuses on decreasing the secondary bacterial and fungal infection 
of limbs and genitals whose lymphatic function has already been compromised by 
filarial infection, since secondary infection is the primary pathogenetic determinant 
of worsening lymphoedema and elephantiasis (Ottesen, 2000). 
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The importance of mapping and surveillance studies is to identify endemic areas so 
. . 
that repeated cycles of mass drug administration (MDA) can be performed in order to 
reduce both infection prevalence and transmission rates to levels below those 
required for sustained transmission (Ottesen et a/., 1997; Molyneux, 2001; Ottesen, 
2006; Weil and Ramzy, 2006). To this end, sensitive and specific field-applicable 
diagnostic tools are required for mapping the distribution of the disease and 
monitoring various phases of the program. Many endemic areas for LF are remote 
and have poor access to well-equipped laboratories, thus a rapid and field-applicable 
diagnostic test is important to ensure that it can be performed easily by field workers 
while at the same time gives reliable and reproducible results. Furthermore, an 
important technical consideration to ascertain the success of this programme is the 
need for sensitive tests which obviates night blood sampling for proper mapping and 
surveillance exercises after the cessation of the mass-treatment (Ottesen eta/., 1997). 
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1.1.7 Brugia Rapid™ 
Brugia Rapid™ is a dipstick test format that utilized BmRl recombinant antigen for 
the detection of brugian filariasis. This rapid test is based on the significantly 
elevated level oflgG4 antibody in active infection (Rahmah et al., 2001b, 2003b). In 
this test, the anti-filarial antibodies in patient sera will react with this antigen, 
followed by binding of this complex with monoclonal anti-human IgG4 conjugated 
to colloidal gold. Thus, samples containing anti-filarial IgG4 antibodies that re~ct 
specifically to the antigen will result in the appearance of a purple-reddish colour at 
the test line (Rahmah eta/., 2003b). 
Previously, this test was performed in an ELISA format known as Brugia-ELISA. 
Evaluation studies on this test demonstrated the specificity rates of 95.6-100%, the 
sensitivity rates of 96-100%, the positive predictive values of 75-100%, and the 
negative predictive values of 98.9-100% (Rahmah eta/., 200la). However, since this 
test is more suitable for laboratory rather than field usc, therefore the format of the 
test has been further developed into a rapid immunochromatographic dipstick test 
and cassette format, which later was named as Brugia Rapid™ test. This new format 
is easy to perform, rapid and robust. Most importantly, it does not require any night 
blood sampling and does not need any laboratory facilities; make it useful for field-
work in remote areas. 
Evaluation studies of this test have been performed to validate the sensitivity and 
specificity of the rapid test which involved both endemic and non-endemic areas of 
filariasis. The results showed 97% sensitivity, 99% specificity, 97% positive 
predictive value, and 99% negative predictive value (Rahmah et al., 2001 b; 2003a). 
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In the past, the mapping activities for LF endemicity has been hampered by the lack 
of data on the geographical distribution of levels of infectious or disease (Micheal 
and Bundy, 1997). With this regard, other than for patient diagnosis, this assay is 
very useful for mapping of endemic areas, and surveillance post- mass treatment 
towards helping to achieve the goals of the Global Elimination Program for 
Lymphatic Filariasis (GPELF). 
1.2 E. coli fermentation 
1.2.1 History 
In the 19th century, interest in microbial fermentations has received great attention 
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when people started to realize the potential use of microbes especially in the 
production of drinks and dairy products. E.coli has been the most widely used 
prokaryotic host because it is well characterized in terms of its molecular genetics, 
physiology, and expression system (Makrides, 1996; Choi and Lee, 2004), and thus 
was the pioneer organism for large scale fermentation studies. Since early 1970s, 
growing E. coli to high densities has been the subject of numerous studies where 
initially it was focused on high cell density growth of E. coli to investigate the limits 
of bacterial growth in liquid culture and to obtain large quantities of exponentially 
grown E.coli needed for biochemical studies (Choi et al., 2006). Besides E.coli, the 
use of microorganisms such as Pichia pastoris (Stratton et al., 1998), Saccharomyces 
cerevisiae (Lee et al., 1994), Candida brassicae (Yano et al., 1985) and Bacillus 
subtilis (Park et al., 1992) are very commonly grown to hi'gh cell density using 
fem1entation methods. However, growing E. coli to a high cell density culture has 
become the method of choice for the production of recombinant proteins mainly 
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because of the high volumetric productivities associated with this method (Choi et 
al., 2006). 
Large scale fermentation in the fermenter has the added advantage of increased cost-
effectiveness, enhanced downstream processing, reduced wastewater, lower 
production cost and a reduced investment in equipment (Choi et al., 2006). The 
development of this technique for E.coli has facilitated the production of 
recombinant proteins and non-protein biomolecular products such as amino acids, 
primary and secondary metabolites with high productivities (Jeong and Lee, 1999; 
Gerigk eta/., 2002; Mijts and Schmidt-Dannert, 2003; Jeong et a/2004; Choi eta/., 
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2006). Considering the commercial potential of a synthetic human IL-lra, Zanette 
and co-workers (1998) has highlighted the economical process for the production of 
this cytokine in a 50L scale fermentation process of E.coli. Such similar study also 
has been demonstrated by Yazdani and co-workers (2004) for the production of 
recombinant malarial antigen, PvRII in E.coli in lOL culture volume. In addition, 
Janardhan and co-workers (2007) has established the production of WbSXP-1 
recombinant protein for diagnostic application in lymphatic filariasis. 
The increasing industrial demand for robust fermentation control requires improved 
strategy to increase the production of the target product. In an effort to further 
improve the fermentation technique, the · principal strategy focuses on the 
development of growth medium, culture conditions and nutrient feeding strategy. 
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1.2.2 Characteristics of E.coli 
E.coli is a Gram negative bacterium which does not produce endospores in response 
to starvation conditions (Rinas et a!., 1995). It is generally grown under aerobic 
conditions because anaerobic growth provides less energy for metabolic processes 
such as protein synthesis (Xu et a!. 1999; Manderson et a!. 2006). There are four 
different phases in E. coli's growth namely lag, log, stationary and death phase. At 
each phase, E. coli has different morphological state and the medium has different 
condition in terms of nutrient availability and levels of inhibitory by-product. When 
the bacteria first enter into a new culture medium, the cells will take time to adapt to 
the new environment. Consequently, the slow growth is observed during the lag 
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phase as there is no or very little cell division. Conversely, in the log phase, there is a 
rapid exponential growth of the cells whereby nutrients are metabolized at its 
maximum speed until one of the nutrients is depleted and starts limiting the growth. 
The rate at which cells grow during this phase is known as the growth rate (k), and 
the time it takes for the cells to double is known as the generation time (d). However 
the cells start to reduce their metabolic activity as a consequence of depleted 
nutrients during the stationary phase, where the rate of cells dividing is equal to the 
rate of cell death. When the cells are unable to resume division and cannot survive 
the harsh conditions caused by few nutrients availability and too much toxins, the 
cells start to die which result in a decrease in the numbers of cells within the system. 
Synthesizing recombinant protein at the beginning of the culture may not be 
advantageous because many proteins are sensitive to proteases, thus an early protein 
production will increase to proteolytic degradation before the final harvest (Aucoin et 
a/., 2006) and can unnecessarily slow down the doubling time of the bacterial cells 
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(Manderson et al., 2006). Converse! y, induction at the stationary phase reduces 
culture viability and could lead to production of proteases which can breakdown the 
desired recombinant protein (Chisti, 1998; Corchero et al., 2001; Manderson et al., 
2006). Therefore, the recombinant protein production is generally induced at late 
exponential growth phase, where the induction at this stage will promote 
exponentially grown cells to express the target protein. 
E. coli cells consist of inner and outer membranes that divide the organism into three 
compartments; the cytoplasm, the periplasm and the extracellular space where the 
recombinant proteins can be targeted to one of these compartments (Choi et al., 
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2006). However, many research group have focused on the secretory production 
system to target the recombinant protein productio? into the periplasmic space (Choi 
and Lee, 2004; Choi et al., 2006) based on some exclusive characteristics. One of it 
is because periplasmic space is known to have less protease activity which in tum 
would maintain the stability of the protein by prevention of proteolytic degradation. 
In addition, the purification of the target protein could be more simplified as the 
periplasmic space contains less native host proteins (Choi et al., 2006). 
As a whole, the unique characteristic of recombinant E. coli as an. economical host, 
coupled with the advent technology in recombinant DNA and large-scale culture 
processes has enabled high production of therapeutic proteins such as insulin, 
antibiotics, hormones and specialized proteins such as antibodies at industrial scale. 
In this case, Ouelette et al. (2003) reported that 10 mg/1 of human rhiL-7 was 
successfully achieved in 1000 L batch culture of E.coli HMS174 (DE3). In the 
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production of TGF-a-PE40 (a candidate anti-tumor agent), Lee and co-workers 
(1997) had successfully obtained 950 mg/1 ofTGF-a-PE40 in 800 L fermenters. 
1.2.3 Fermenter 
The common types of fermenter used for industrial fermentation are the stirred-tank 
fermenter (STF) (Knorre et al., 1990), air-lift fermenter (ALF) (Holst et al., 1997) 
and dialysis reactor (Nakano et al., 1997) (Riesenberg and Guthke, 1999). However, 
the most frequently used for industrial application, especially in the pharmaceutical 
industry, is the conventional mixing vessel STF. 
Commonly, the STF (Figure 1.4) is fitted with baffles to prevent a large central 
vortex being formed and improve mixing by breaking the liquid flow. For an 
efficient mixing, high turbulence is required; hence this is created by the vortex field 
which forms behind the blades. The sparger located underneath the disk allows all 
the gas to flow through into the fermemer. Furthermore, the temperature in a vessel 
can be controlled by removing heat by means of water circulating through a jacket 
outside the vessel. 
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In fed-batch fermentation, monitoring and controlling the running process can be 
assisted with the presence of software. In this study, a 5 L fermenter (Biostat B5, B. 
Braun International, Germany) was used to carry out the whole experiment. This 
stirred tank fermenter is equipped with data acquisition and automated feeding 
system controlled by the Multifermenter Control System Software (MFCS) supplied 
by B. Braun International, Germany, which allows monitoring and control of 
substrate feeding into the culture and other fermenter operating variables. The B. 
Braun's DCU was used as a front-end controller and a PC was connected to the 
MFCS-Win computer via a local network to enable data exchange via a software 
interface. The fermenter is also equipped with important control modules such as 
I 
probes for temperature, pH, dissolved oxygen (DO) and pumps for feeding of the 
substrate to the culture. The probes provide direct measurements of temperature, pH 
and dissolved oxygen concentration during the cultivation process. Figure 1.5 shows 
the example of instrument set-up for a typical fermentation process. 
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1.2.4 Mode offermentation 
Protein production in E.coli can be increased significantly through the use of large 
scale cell cultivation performed in fermenter. There are four main modes of 
fermenter operation namely batch, fed-batch, repeated batch and continuous 
fermentation. 
1.2.4.1 Batch fermentation 
In batch cultures, all substrate components are added initially, except for oxygen and 
pH-controlling agents. Typically, cells will grow exponentially until some substrate 
is exhausted or the concentration of by-products becomes inhibiting. The major 
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disadvantage of batch culture is the exhaustion of nutrients and substrate that may 
cause the system to be retarded, thus affected the pattern of cell growth to reach 
death phase quickly in an old culture. 
1.2.4.2 Continuous fermentation 
In contrast to the batch culture, continuous cultures are mostly operated at steady 
state with an incoming substrate feed flew in balance with an outgoing flow. The 
substrate feed rate is normally growth limiting and this gives a possibility to control 
the cell growth at a constant physiological state and growth rate. Continuous cultures 
outperform batch culture economically by eliminating the inherent downtime that is 
lost for cleaning, sterilization, and the re-establishing of biomass within the 
fermenter. However, contaminations represent a major problem in continuous 
culture, a reason why this process is much less common than batch process m 
industria] microbial fermentation (El-Mansi et al., 2006). 
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1.2.4.3 Fed-batch fermentation 
In fed-batch cultures, nutrient feeding substrate is added at certain mode with no 
removal of the cultures from the reactor. By adding nutrient this way, cells are 
maintained under low substrate or nutrient conditions. Moreover, the production of 
by-inhibitory product can be prevented by controlling the nutrient supply 
appropriately. Thus, it allows growth to be prolonged where it is possible to 
overcome oxygen limitation and consequently, high biomass and product formation 
can be achieved (Manderson et al., 2006). For the successful large scale bacterial 
cultivation via fed-batch fermentation allowing high target protein production, the 
selection of nutrient feeding strategy is critical because it affects the metabolic 
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pathway fluxes; therefore it affects the maximum attainable cell concentration, the 
specific productivity of recombinant proteins and the formation of by-products (Choi 
et al., 2006). In fed-batch operation, the initiation, processing and harvesting modes 
are utilized in a single sequence, contrary to cyclic operation (repeated batch) which 
involves the repetitive cycle of processing and harvesting modes. 
1.2.5 Cultivation in fed-batch fermentation 
In an effort to further improve the fermentation strategy, a number of studies on the 
effect of growth medium, nutrient feeding strategies and culture conditions on 
recombinant protein production have been carried out. Studies also have shown that 
the fermentation variables such as temperature, pH, and dissolved oxygen level can 
affect the transcription, translation, proteolytic activity, secretion, production levels, 
and stability of the protein (Choi et al., 2006). 
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1.2.5.1 Growth medium 
The most important factors that need to be considered when developing a medium 
are the concentrations and the ratios of the carbon/ energy sources, nitrogen sources, 
vitamins and trace elements (Riesenberg et al., 1991; Kleman and Strohl, 1992). The 
composition of the cell growth medium may have significant metabolic effects on 
both the cells and protein production (Jana and Deb, 2005). In general, the available 
media for bacterial cultivation can be grouped into two different categories namely 
defined medium and complex medium. 
Defined medium is a medium in which the exact chemical composition is known. A 
I 
defined medium that provides only the exact nutrients (including any growth factor) 
needed by the organism for growth is known as minimal medium. This chemically-
defined medium is of value in studying the minimal nutritional requirements of 
microorganisms, for enrichment of the cultures, and for a wide variety of 
physiological studies. Therefore, use of chemically defined medium in producing 
recombinant proteins is a common practice because these media attain more 
consistent titres, allowing easier process control, monitoring, and simplify the 
downstream recovery of the target protein (Lim and Jung, 1998; Zhang and 
Greasham, 1999; Cserjan-Puschmann et al., 1999; Kweon et al., 2001). However, it 
is noted that this medium is generally known to produce slower growth and lower 
protein production titres as compared to complex medium (Zanette et al., 1998; 
Manderson et al., 2006). 
A complex medium contains some complex ingredients in which the exact 
constituent of the medium is not known, such as yeast extract, blood, or casein 
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